Low Complement C4 Predicts Improvement of Kidney Function After Direct‐Acting Antiviral Therapy for Hepatitis C Virus

by Meghan E. Sise, Ian Strohbehn, Donald Chute, Kathleen E. Corey, Dahlene N. Fusco, Venkata S Sabbisetti, Sushrut S. Waikar, Raymond T. Chung
Published 2020-08-01

Efficacy and Safety of Direct Acting Antivirals in Kidney Transplant Recipients with Chronic Hepatitis C Virus Infection.

by Ming V Lin, Meghan E Sise, Martha Pavlakis, Beth M Amundsen, Donald Chute, Anna E Rutherford, Raymond T Chung, Michael P Curry, Jasmine M Hanifi, Steve Gabardi, Anil Chandraker, Eliot C Heher, Nahel Elias, Leonardo V Riella
Published 2016-01-01

Lupus-Like Immune Complex-Mediated Glomerulonephritis in Patients With Hepatitis C Virus Infection Treated With Oral, Interferon-Free, Direct-Acting Antiviral Therapy

by Meghan E. Sise, Jessica Wisocky, Ivy A. Rosales, Donald Chute, Jacinta A. Holmes, Kristin M. Corapi, Jodie L. Babitt, Jessica S. Tangren, Nikroo Hashemi, Andrew L. Lundquist, Winfred W. Williams, David B. Mount, Karin L. Andersson, Helmut G. Rennke, R. Neal Smith, Robert Colvin, Ravi I. Thadhani, Raymond T. Chung
Published 2016-09-01